Cerevance has said it plans to move on to late-stage trials of its first-in-class Parkinson's disease drug CVN424 after hitting the mark in a phase 2 proof-of-concept study. The Boston-based biotech ...
How SMBs use threat research and MDR to build a defensive edge We speak to Director of ESET Threat Research Jean-Ian Boutin about where solutions that blend advanced technology with human expertise ...
Consistent SQL practice across varied platforms builds real job-ready confidence. Guided lessons help beginners, while timed challenges sharpen interview performance. Real datasets improve practical ...
Choose a SQL Server trial, edition, tool, or connector that best meets your data and workload needs. Accelerate AI development with SQL Server 2025, the AI-ready enterprise database with best-in-class ...
Web application for sizing Oracle Exadata X11M on-premises systems based on workload data extracted from Oracle Enterprise Manager (OEM) 24ai. Analyzes current database workloads (CPU, memory, storage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results